nodes	percent_of_prediction	percent_of_DWPC	metapath
Perflutren—Urticaria—Fluorouracil—urinary bladder cancer	0.00121	0.00121	CcSEcCtD
Perflutren—Conjunctivitis—Methotrexate—urinary bladder cancer	0.00121	0.00121	CcSEcCtD
Perflutren—Body temperature increased—Fluorouracil—urinary bladder cancer	0.0012	0.0012	CcSEcCtD
Perflutren—Eosinophilia—Doxorubicin—urinary bladder cancer	0.00119	0.00119	CcSEcCtD
Perflutren—Feeling abnormal—Cisplatin—urinary bladder cancer	0.00119	0.00119	CcSEcCtD
Perflutren—Paraesthesia—Etoposide—urinary bladder cancer	0.00119	0.00119	CcSEcCtD
Perflutren—Dyspnoea—Etoposide—urinary bladder cancer	0.00118	0.00118	CcSEcCtD
Perflutren—Vomiting—Thiotepa—urinary bladder cancer	0.00117	0.00117	CcSEcCtD
Perflutren—Rash—Thiotepa—urinary bladder cancer	0.00116	0.00116	CcSEcCtD
Perflutren—Dermatitis—Thiotepa—urinary bladder cancer	0.00116	0.00116	CcSEcCtD
Perflutren—Headache—Thiotepa—urinary bladder cancer	0.00115	0.00115	CcSEcCtD
Perflutren—Gastrointestinal disorder—Etoposide—urinary bladder cancer	0.00114	0.00114	CcSEcCtD
Perflutren—Body temperature increased—Cisplatin—urinary bladder cancer	0.00114	0.00114	CcSEcCtD
Perflutren—Fatigue—Etoposide—urinary bladder cancer	0.00114	0.00114	CcSEcCtD
Perflutren—Neuropathy peripheral—Epirubicin—urinary bladder cancer	0.00114	0.00114	CcSEcCtD
Perflutren—Pain—Etoposide—urinary bladder cancer	0.00113	0.00113	CcSEcCtD
Perflutren—Conjunctivitis—Epirubicin—urinary bladder cancer	0.00113	0.00113	CcSEcCtD
Perflutren—Hypersensitivity—Fluorouracil—urinary bladder cancer	0.00112	0.00112	CcSEcCtD
Perflutren—Haemoglobin—Methotrexate—urinary bladder cancer	0.00112	0.00112	CcSEcCtD
Perflutren—Haemorrhage—Methotrexate—urinary bladder cancer	0.00111	0.00111	CcSEcCtD
Perflutren—Asthenia—Gemcitabine—urinary bladder cancer	0.00111	0.00111	CcSEcCtD
Perflutren—Pharyngitis—Methotrexate—urinary bladder cancer	0.00111	0.00111	CcSEcCtD
Perflutren—Pruritus—Gemcitabine—urinary bladder cancer	0.0011	0.0011	CcSEcCtD
Perflutren—Nausea—Thiotepa—urinary bladder cancer	0.00109	0.00109	CcSEcCtD
Perflutren—Feeling abnormal—Etoposide—urinary bladder cancer	0.00109	0.00109	CcSEcCtD
Perflutren—Gastrointestinal pain—Etoposide—urinary bladder cancer	0.00108	0.00108	CcSEcCtD
Perflutren—Pruritus—Fluorouracil—urinary bladder cancer	0.00108	0.00108	CcSEcCtD
Perflutren—Visual impairment—Methotrexate—urinary bladder cancer	0.00107	0.00107	CcSEcCtD
Perflutren—Hypersensitivity—Cisplatin—urinary bladder cancer	0.00106	0.00106	CcSEcCtD
Perflutren—Bradycardia—Epirubicin—urinary bladder cancer	0.00106	0.00106	CcSEcCtD
Perflutren—Diarrhoea—Gemcitabine—urinary bladder cancer	0.00106	0.00106	CcSEcCtD
Perflutren—Neuropathy peripheral—Doxorubicin—urinary bladder cancer	0.00105	0.00105	CcSEcCtD
Perflutren—Urticaria—Etoposide—urinary bladder cancer	0.00105	0.00105	CcSEcCtD
Perflutren—Haemoglobin—Epirubicin—urinary bladder cancer	0.00105	0.00105	CcSEcCtD
Perflutren—Rhinitis—Epirubicin—urinary bladder cancer	0.00105	0.00105	CcSEcCtD
Perflutren—Body temperature increased—Etoposide—urinary bladder cancer	0.00105	0.00105	CcSEcCtD
Perflutren—Abdominal pain—Etoposide—urinary bladder cancer	0.00105	0.00105	CcSEcCtD
Perflutren—Conjunctivitis—Doxorubicin—urinary bladder cancer	0.00105	0.00105	CcSEcCtD
Perflutren—Haemorrhage—Epirubicin—urinary bladder cancer	0.00104	0.00104	CcSEcCtD
Perflutren—Eye disorder—Methotrexate—urinary bladder cancer	0.00104	0.00104	CcSEcCtD
Perflutren—Diarrhoea—Fluorouracil—urinary bladder cancer	0.00104	0.00104	CcSEcCtD
Perflutren—Tinnitus—Methotrexate—urinary bladder cancer	0.00104	0.00104	CcSEcCtD
Perflutren—Hypoaesthesia—Epirubicin—urinary bladder cancer	0.00104	0.00104	CcSEcCtD
Perflutren—Asthenia—Cisplatin—urinary bladder cancer	0.00104	0.00104	CcSEcCtD
Perflutren—Pharyngitis—Epirubicin—urinary bladder cancer	0.00104	0.00104	CcSEcCtD
Perflutren—Cardiac disorder—Methotrexate—urinary bladder cancer	0.00103	0.00103	CcSEcCtD
Perflutren—Connective tissue disorder—Epirubicin—urinary bladder cancer	0.00103	0.00103	CcSEcCtD
Perflutren—Angiopathy—Methotrexate—urinary bladder cancer	0.00101	0.00101	CcSEcCtD
Perflutren—Immune system disorder—Methotrexate—urinary bladder cancer	0.00101	0.00101	CcSEcCtD
Perflutren—Dizziness—Fluorouracil—urinary bladder cancer	0.00101	0.00101	CcSEcCtD
Perflutren—Visual impairment—Epirubicin—urinary bladder cancer	0.00101	0.00101	CcSEcCtD
Perflutren—Mediastinal disorder—Methotrexate—urinary bladder cancer	0.001	0.001	CcSEcCtD
Perflutren—Chills—Methotrexate—urinary bladder cancer	0.001	0.001	CcSEcCtD
Perflutren—Diarrhoea—Cisplatin—urinary bladder cancer	0.000988	0.000988	CcSEcCtD
Perflutren—Vomiting—Gemcitabine—urinary bladder cancer	0.000985	0.000985	CcSEcCtD
Perflutren—Bradycardia—Doxorubicin—urinary bladder cancer	0.000983	0.000983	CcSEcCtD
Perflutren—Rash—Gemcitabine—urinary bladder cancer	0.000977	0.000977	CcSEcCtD
Perflutren—Dermatitis—Gemcitabine—urinary bladder cancer	0.000976	0.000976	CcSEcCtD
Perflutren—Eye disorder—Epirubicin—urinary bladder cancer	0.000975	0.000975	CcSEcCtD
Perflutren—Hypersensitivity—Etoposide—urinary bladder cancer	0.000974	0.000974	CcSEcCtD
Perflutren—Tinnitus—Epirubicin—urinary bladder cancer	0.000973	0.000973	CcSEcCtD
Perflutren—Erythema—Methotrexate—urinary bladder cancer	0.000971	0.000971	CcSEcCtD
Perflutren—Haemoglobin—Doxorubicin—urinary bladder cancer	0.00097	0.00097	CcSEcCtD
Perflutren—Headache—Gemcitabine—urinary bladder cancer	0.00097	0.00097	CcSEcCtD
Perflutren—Cardiac disorder—Epirubicin—urinary bladder cancer	0.000968	0.000968	CcSEcCtD
Perflutren—Flushing—Epirubicin—urinary bladder cancer	0.000968	0.000968	CcSEcCtD
Perflutren—Vomiting—Fluorouracil—urinary bladder cancer	0.000968	0.000968	CcSEcCtD
Perflutren—Rhinitis—Doxorubicin—urinary bladder cancer	0.000968	0.000968	CcSEcCtD
Perflutren—Haemorrhage—Doxorubicin—urinary bladder cancer	0.000965	0.000965	CcSEcCtD
Perflutren—Hypoaesthesia—Doxorubicin—urinary bladder cancer	0.000961	0.000961	CcSEcCtD
Perflutren—Rash—Fluorouracil—urinary bladder cancer	0.00096	0.00096	CcSEcCtD
Perflutren—Dermatitis—Fluorouracil—urinary bladder cancer	0.000959	0.000959	CcSEcCtD
Perflutren—Pharyngitis—Doxorubicin—urinary bladder cancer	0.000958	0.000958	CcSEcCtD
Perflutren—Headache—Fluorouracil—urinary bladder cancer	0.000954	0.000954	CcSEcCtD
Perflutren—Dysgeusia—Methotrexate—urinary bladder cancer	0.00095	0.00095	CcSEcCtD
Perflutren—Asthenia—Etoposide—urinary bladder cancer	0.000949	0.000949	CcSEcCtD
Perflutren—Connective tissue disorder—Doxorubicin—urinary bladder cancer	0.000949	0.000949	CcSEcCtD
Perflutren—Angiopathy—Epirubicin—urinary bladder cancer	0.000947	0.000947	CcSEcCtD
Perflutren—Immune system disorder—Epirubicin—urinary bladder cancer	0.000942	0.000942	CcSEcCtD
Perflutren—Mediastinal disorder—Epirubicin—urinary bladder cancer	0.00094	0.00094	CcSEcCtD
Perflutren—Back pain—Methotrexate—urinary bladder cancer	0.000939	0.000939	CcSEcCtD
Perflutren—Chills—Epirubicin—urinary bladder cancer	0.000936	0.000936	CcSEcCtD
Perflutren—Pruritus—Etoposide—urinary bladder cancer	0.000936	0.000936	CcSEcCtD
Perflutren—Arrhythmia—Epirubicin—urinary bladder cancer	0.000932	0.000932	CcSEcCtD
Perflutren—Visual impairment—Doxorubicin—urinary bladder cancer	0.00093	0.00093	CcSEcCtD
Perflutren—Nausea—Gemcitabine—urinary bladder cancer	0.00092	0.00092	CcSEcCtD
Perflutren—Vomiting—Cisplatin—urinary bladder cancer	0.000918	0.000918	CcSEcCtD
Perflutren—Vision blurred—Methotrexate—urinary bladder cancer	0.000915	0.000915	CcSEcCtD
Perflutren—Rash—Cisplatin—urinary bladder cancer	0.00091	0.00091	CcSEcCtD
Perflutren—Dermatitis—Cisplatin—urinary bladder cancer	0.000909	0.000909	CcSEcCtD
Perflutren—Erythema—Epirubicin—urinary bladder cancer	0.000908	0.000908	CcSEcCtD
Perflutren—Diarrhoea—Etoposide—urinary bladder cancer	0.000905	0.000905	CcSEcCtD
Perflutren—Nausea—Fluorouracil—urinary bladder cancer	0.000904	0.000904	CcSEcCtD
Perflutren—Eye disorder—Doxorubicin—urinary bladder cancer	0.000902	0.000902	CcSEcCtD
Perflutren—Ill-defined disorder—Methotrexate—urinary bladder cancer	0.000901	0.000901	CcSEcCtD
Perflutren—Tinnitus—Doxorubicin—urinary bladder cancer	0.0009	0.0009	CcSEcCtD
Perflutren—Cardiac disorder—Doxorubicin—urinary bladder cancer	0.000896	0.000896	CcSEcCtD
Perflutren—Flushing—Doxorubicin—urinary bladder cancer	0.000896	0.000896	CcSEcCtD
Perflutren—Dysgeusia—Epirubicin—urinary bladder cancer	0.000889	0.000889	CcSEcCtD
Perflutren—Back pain—Epirubicin—urinary bladder cancer	0.000879	0.000879	CcSEcCtD
Perflutren—Angiopathy—Doxorubicin—urinary bladder cancer	0.000876	0.000876	CcSEcCtD
Perflutren—Malaise—Methotrexate—urinary bladder cancer	0.000875	0.000875	CcSEcCtD
Perflutren—Dizziness—Etoposide—urinary bladder cancer	0.000875	0.000875	CcSEcCtD
Perflutren—Muscle spasms—Epirubicin—urinary bladder cancer	0.000873	0.000873	CcSEcCtD
Perflutren—Immune system disorder—Doxorubicin—urinary bladder cancer	0.000872	0.000872	CcSEcCtD
Perflutren—Vertigo—Methotrexate—urinary bladder cancer	0.000872	0.000872	CcSEcCtD
Perflutren—Mediastinal disorder—Doxorubicin—urinary bladder cancer	0.00087	0.00087	CcSEcCtD
Perflutren—Leukopenia—Methotrexate—urinary bladder cancer	0.000869	0.000869	CcSEcCtD
Perflutren—Chills—Doxorubicin—urinary bladder cancer	0.000866	0.000866	CcSEcCtD
Perflutren—Arrhythmia—Doxorubicin—urinary bladder cancer	0.000862	0.000862	CcSEcCtD
Perflutren—Nausea—Cisplatin—urinary bladder cancer	0.000857	0.000857	CcSEcCtD
Perflutren—Vision blurred—Epirubicin—urinary bladder cancer	0.000856	0.000856	CcSEcCtD
Perflutren—Cough—Methotrexate—urinary bladder cancer	0.000847	0.000847	CcSEcCtD
Perflutren—Ill-defined disorder—Epirubicin—urinary bladder cancer	0.000843	0.000843	CcSEcCtD
Perflutren—Convulsion—Methotrexate—urinary bladder cancer	0.000841	0.000841	CcSEcCtD
Perflutren—Vomiting—Etoposide—urinary bladder cancer	0.000841	0.000841	CcSEcCtD
Perflutren—Erythema—Doxorubicin—urinary bladder cancer	0.00084	0.00084	CcSEcCtD
Perflutren—Agitation—Epirubicin—urinary bladder cancer	0.000835	0.000835	CcSEcCtD
Perflutren—Rash—Etoposide—urinary bladder cancer	0.000834	0.000834	CcSEcCtD
Perflutren—Dermatitis—Etoposide—urinary bladder cancer	0.000833	0.000833	CcSEcCtD
Perflutren—Headache—Etoposide—urinary bladder cancer	0.000828	0.000828	CcSEcCtD
Perflutren—Arthralgia—Methotrexate—urinary bladder cancer	0.000826	0.000826	CcSEcCtD
Perflutren—Myalgia—Methotrexate—urinary bladder cancer	0.000826	0.000826	CcSEcCtD
Perflutren—Chest pain—Methotrexate—urinary bladder cancer	0.000826	0.000826	CcSEcCtD
Perflutren—Dysgeusia—Doxorubicin—urinary bladder cancer	0.000823	0.000823	CcSEcCtD
Perflutren—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—urinary bladder cancer	0.000821	0.000821	CcSEcCtD
Perflutren—Malaise—Epirubicin—urinary bladder cancer	0.000819	0.000819	CcSEcCtD
Perflutren—Discomfort—Methotrexate—urinary bladder cancer	0.000816	0.000816	CcSEcCtD
Perflutren—Vertigo—Epirubicin—urinary bladder cancer	0.000816	0.000816	CcSEcCtD
Perflutren—Syncope—Epirubicin—urinary bladder cancer	0.000815	0.000815	CcSEcCtD
Perflutren—Leukopenia—Epirubicin—urinary bladder cancer	0.000813	0.000813	CcSEcCtD
Perflutren—Back pain—Doxorubicin—urinary bladder cancer	0.000813	0.000813	CcSEcCtD
Perflutren—Muscle spasms—Doxorubicin—urinary bladder cancer	0.000808	0.000808	CcSEcCtD
Perflutren—Palpitations—Epirubicin—urinary bladder cancer	0.000803	0.000803	CcSEcCtD
Perflutren—Loss of consciousness—Epirubicin—urinary bladder cancer	0.000798	0.000798	CcSEcCtD
Perflutren—Cough—Epirubicin—urinary bladder cancer	0.000793	0.000793	CcSEcCtD
Perflutren—Anaphylactic shock—Methotrexate—urinary bladder cancer	0.000792	0.000792	CcSEcCtD
Perflutren—Vision blurred—Doxorubicin—urinary bladder cancer	0.000792	0.000792	CcSEcCtD
Perflutren—Convulsion—Epirubicin—urinary bladder cancer	0.000787	0.000787	CcSEcCtD
Perflutren—Nausea—Etoposide—urinary bladder cancer	0.000786	0.000786	CcSEcCtD
Perflutren—Hypertension—Epirubicin—urinary bladder cancer	0.000784	0.000784	CcSEcCtD
Perflutren—Ill-defined disorder—Doxorubicin—urinary bladder cancer	0.00078	0.00078	CcSEcCtD
Perflutren—Nervous system disorder—Methotrexate—urinary bladder cancer	0.000777	0.000777	CcSEcCtD
Perflutren—Chest pain—Epirubicin—urinary bladder cancer	0.000773	0.000773	CcSEcCtD
Perflutren—Arthralgia—Epirubicin—urinary bladder cancer	0.000773	0.000773	CcSEcCtD
Perflutren—Myalgia—Epirubicin—urinary bladder cancer	0.000773	0.000773	CcSEcCtD
Perflutren—Agitation—Doxorubicin—urinary bladder cancer	0.000772	0.000772	CcSEcCtD
Perflutren—Skin disorder—Methotrexate—urinary bladder cancer	0.000769	0.000769	CcSEcCtD
Perflutren—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—urinary bladder cancer	0.000768	0.000768	CcSEcCtD
Perflutren—Hyperhidrosis—Methotrexate—urinary bladder cancer	0.000766	0.000766	CcSEcCtD
Perflutren—Discomfort—Epirubicin—urinary bladder cancer	0.000764	0.000764	CcSEcCtD
Perflutren—Malaise—Doxorubicin—urinary bladder cancer	0.000758	0.000758	CcSEcCtD
Perflutren—Dry mouth—Epirubicin—urinary bladder cancer	0.000756	0.000756	CcSEcCtD
Perflutren—Vertigo—Doxorubicin—urinary bladder cancer	0.000755	0.000755	CcSEcCtD
Perflutren—Syncope—Doxorubicin—urinary bladder cancer	0.000754	0.000754	CcSEcCtD
Perflutren—Leukopenia—Doxorubicin—urinary bladder cancer	0.000752	0.000752	CcSEcCtD
Perflutren—Palpitations—Doxorubicin—urinary bladder cancer	0.000743	0.000743	CcSEcCtD
Perflutren—Anaphylactic shock—Epirubicin—urinary bladder cancer	0.000741	0.000741	CcSEcCtD
Perflutren—Oedema—Epirubicin—urinary bladder cancer	0.000741	0.000741	CcSEcCtD
Perflutren—Hypotension—Methotrexate—urinary bladder cancer	0.00074	0.00074	CcSEcCtD
Perflutren—Loss of consciousness—Doxorubicin—urinary bladder cancer	0.000739	0.000739	CcSEcCtD
Perflutren—Cough—Doxorubicin—urinary bladder cancer	0.000733	0.000733	CcSEcCtD
Perflutren—Shock—Epirubicin—urinary bladder cancer	0.000729	0.000729	CcSEcCtD
Perflutren—Convulsion—Doxorubicin—urinary bladder cancer	0.000728	0.000728	CcSEcCtD
Perflutren—Nervous system disorder—Epirubicin—urinary bladder cancer	0.000727	0.000727	CcSEcCtD
Perflutren—Hypertension—Doxorubicin—urinary bladder cancer	0.000726	0.000726	CcSEcCtD
Perflutren—Tachycardia—Epirubicin—urinary bladder cancer	0.000724	0.000724	CcSEcCtD
Perflutren—Musculoskeletal discomfort—Methotrexate—urinary bladder cancer	0.000722	0.000722	CcSEcCtD
Perflutren—Skin disorder—Epirubicin—urinary bladder cancer	0.00072	0.00072	CcSEcCtD
Perflutren—Hyperhidrosis—Epirubicin—urinary bladder cancer	0.000717	0.000717	CcSEcCtD
Perflutren—Myalgia—Doxorubicin—urinary bladder cancer	0.000716	0.000716	CcSEcCtD
Perflutren—Chest pain—Doxorubicin—urinary bladder cancer	0.000716	0.000716	CcSEcCtD
Perflutren—Arthralgia—Doxorubicin—urinary bladder cancer	0.000716	0.000716	CcSEcCtD
Perflutren—Paraesthesia—Methotrexate—urinary bladder cancer	0.000711	0.000711	CcSEcCtD
Perflutren—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—urinary bladder cancer	0.000711	0.000711	CcSEcCtD
Perflutren—Discomfort—Doxorubicin—urinary bladder cancer	0.000707	0.000707	CcSEcCtD
Perflutren—Dyspnoea—Methotrexate—urinary bladder cancer	0.000706	0.000706	CcSEcCtD
Perflutren—Dry mouth—Doxorubicin—urinary bladder cancer	0.0007	0.0007	CcSEcCtD
Perflutren—Dyspepsia—Methotrexate—urinary bladder cancer	0.000697	0.000697	CcSEcCtD
Perflutren—Hypotension—Epirubicin—urinary bladder cancer	0.000693	0.000693	CcSEcCtD
Perflutren—Oedema—Doxorubicin—urinary bladder cancer	0.000686	0.000686	CcSEcCtD
Perflutren—Anaphylactic shock—Doxorubicin—urinary bladder cancer	0.000686	0.000686	CcSEcCtD
Perflutren—Gastrointestinal disorder—Methotrexate—urinary bladder cancer	0.000684	0.000684	CcSEcCtD
Perflutren—Fatigue—Methotrexate—urinary bladder cancer	0.000683	0.000683	CcSEcCtD
Perflutren—Pain—Methotrexate—urinary bladder cancer	0.000677	0.000677	CcSEcCtD
Perflutren—Musculoskeletal discomfort—Epirubicin—urinary bladder cancer	0.000675	0.000675	CcSEcCtD
Perflutren—Shock—Doxorubicin—urinary bladder cancer	0.000675	0.000675	CcSEcCtD
Perflutren—Nervous system disorder—Doxorubicin—urinary bladder cancer	0.000673	0.000673	CcSEcCtD
Perflutren—Tachycardia—Doxorubicin—urinary bladder cancer	0.000669	0.000669	CcSEcCtD
Perflutren—Skin disorder—Doxorubicin—urinary bladder cancer	0.000666	0.000666	CcSEcCtD
Perflutren—Paraesthesia—Epirubicin—urinary bladder cancer	0.000666	0.000666	CcSEcCtD
Perflutren—Hyperhidrosis—Doxorubicin—urinary bladder cancer	0.000663	0.000663	CcSEcCtD
Perflutren—Dyspnoea—Epirubicin—urinary bladder cancer	0.000661	0.000661	CcSEcCtD
Perflutren—Feeling abnormal—Methotrexate—urinary bladder cancer	0.000653	0.000653	CcSEcCtD
Perflutren—Dyspepsia—Epirubicin—urinary bladder cancer	0.000653	0.000653	CcSEcCtD
Perflutren—Gastrointestinal pain—Methotrexate—urinary bladder cancer	0.000648	0.000648	CcSEcCtD
Perflutren—Hypotension—Doxorubicin—urinary bladder cancer	0.000641	0.000641	CcSEcCtD
Perflutren—Gastrointestinal disorder—Epirubicin—urinary bladder cancer	0.00064	0.00064	CcSEcCtD
Perflutren—Fatigue—Epirubicin—urinary bladder cancer	0.000639	0.000639	CcSEcCtD
Perflutren—Pain—Epirubicin—urinary bladder cancer	0.000634	0.000634	CcSEcCtD
Perflutren—Urticaria—Methotrexate—urinary bladder cancer	0.000629	0.000629	CcSEcCtD
Perflutren—Body temperature increased—Methotrexate—urinary bladder cancer	0.000626	0.000626	CcSEcCtD
Perflutren—Abdominal pain—Methotrexate—urinary bladder cancer	0.000626	0.000626	CcSEcCtD
Perflutren—Musculoskeletal discomfort—Doxorubicin—urinary bladder cancer	0.000625	0.000625	CcSEcCtD
Perflutren—Paraesthesia—Doxorubicin—urinary bladder cancer	0.000616	0.000616	CcSEcCtD
Perflutren—Dyspnoea—Doxorubicin—urinary bladder cancer	0.000612	0.000612	CcSEcCtD
Perflutren—Feeling abnormal—Epirubicin—urinary bladder cancer	0.000611	0.000611	CcSEcCtD
Perflutren—Gastrointestinal pain—Epirubicin—urinary bladder cancer	0.000606	0.000606	CcSEcCtD
Perflutren—Dyspepsia—Doxorubicin—urinary bladder cancer	0.000604	0.000604	CcSEcCtD
Perflutren—Gastrointestinal disorder—Doxorubicin—urinary bladder cancer	0.000592	0.000592	CcSEcCtD
Perflutren—Fatigue—Doxorubicin—urinary bladder cancer	0.000591	0.000591	CcSEcCtD
Perflutren—Urticaria—Epirubicin—urinary bladder cancer	0.000589	0.000589	CcSEcCtD
Perflutren—Pain—Doxorubicin—urinary bladder cancer	0.000587	0.000587	CcSEcCtD
Perflutren—Abdominal pain—Epirubicin—urinary bladder cancer	0.000586	0.000586	CcSEcCtD
Perflutren—Body temperature increased—Epirubicin—urinary bladder cancer	0.000586	0.000586	CcSEcCtD
Perflutren—Hypersensitivity—Methotrexate—urinary bladder cancer	0.000584	0.000584	CcSEcCtD
Perflutren—Asthenia—Methotrexate—urinary bladder cancer	0.000568	0.000568	CcSEcCtD
Perflutren—Feeling abnormal—Doxorubicin—urinary bladder cancer	0.000565	0.000565	CcSEcCtD
Perflutren—Gastrointestinal pain—Doxorubicin—urinary bladder cancer	0.000561	0.000561	CcSEcCtD
Perflutren—Pruritus—Methotrexate—urinary bladder cancer	0.00056	0.00056	CcSEcCtD
Perflutren—Hypersensitivity—Epirubicin—urinary bladder cancer	0.000546	0.000546	CcSEcCtD
Perflutren—Urticaria—Doxorubicin—urinary bladder cancer	0.000545	0.000545	CcSEcCtD
Perflutren—Abdominal pain—Doxorubicin—urinary bladder cancer	0.000542	0.000542	CcSEcCtD
Perflutren—Body temperature increased—Doxorubicin—urinary bladder cancer	0.000542	0.000542	CcSEcCtD
Perflutren—Diarrhoea—Methotrexate—urinary bladder cancer	0.000542	0.000542	CcSEcCtD
Perflutren—Asthenia—Epirubicin—urinary bladder cancer	0.000532	0.000532	CcSEcCtD
Perflutren—Pruritus—Epirubicin—urinary bladder cancer	0.000524	0.000524	CcSEcCtD
Perflutren—Dizziness—Methotrexate—urinary bladder cancer	0.000524	0.000524	CcSEcCtD
Perflutren—Diarrhoea—Epirubicin—urinary bladder cancer	0.000507	0.000507	CcSEcCtD
Perflutren—Hypersensitivity—Doxorubicin—urinary bladder cancer	0.000505	0.000505	CcSEcCtD
Perflutren—Vomiting—Methotrexate—urinary bladder cancer	0.000504	0.000504	CcSEcCtD
Perflutren—Rash—Methotrexate—urinary bladder cancer	0.000499	0.000499	CcSEcCtD
Perflutren—Dermatitis—Methotrexate—urinary bladder cancer	0.000499	0.000499	CcSEcCtD
Perflutren—Headache—Methotrexate—urinary bladder cancer	0.000496	0.000496	CcSEcCtD
Perflutren—Asthenia—Doxorubicin—urinary bladder cancer	0.000492	0.000492	CcSEcCtD
Perflutren—Dizziness—Epirubicin—urinary bladder cancer	0.00049	0.00049	CcSEcCtD
Perflutren—Pruritus—Doxorubicin—urinary bladder cancer	0.000485	0.000485	CcSEcCtD
Perflutren—Vomiting—Epirubicin—urinary bladder cancer	0.000471	0.000471	CcSEcCtD
Perflutren—Nausea—Methotrexate—urinary bladder cancer	0.000471	0.000471	CcSEcCtD
Perflutren—Diarrhoea—Doxorubicin—urinary bladder cancer	0.000469	0.000469	CcSEcCtD
Perflutren—Rash—Epirubicin—urinary bladder cancer	0.000467	0.000467	CcSEcCtD
Perflutren—Dermatitis—Epirubicin—urinary bladder cancer	0.000467	0.000467	CcSEcCtD
Perflutren—Headache—Epirubicin—urinary bladder cancer	0.000464	0.000464	CcSEcCtD
Perflutren—Dizziness—Doxorubicin—urinary bladder cancer	0.000454	0.000454	CcSEcCtD
Perflutren—Nausea—Epirubicin—urinary bladder cancer	0.00044	0.00044	CcSEcCtD
Perflutren—Vomiting—Doxorubicin—urinary bladder cancer	0.000436	0.000436	CcSEcCtD
Perflutren—Rash—Doxorubicin—urinary bladder cancer	0.000432	0.000432	CcSEcCtD
Perflutren—Dermatitis—Doxorubicin—urinary bladder cancer	0.000432	0.000432	CcSEcCtD
Perflutren—Headache—Doxorubicin—urinary bladder cancer	0.00043	0.00043	CcSEcCtD
Perflutren—Nausea—Doxorubicin—urinary bladder cancer	0.000407	0.000407	CcSEcCtD
